Cargando…
Monoclonal antibodies binding data for SARS-CoV-2 proteins
SARS-CoV-2 pandemic opens up the curiosity of understanding the coronavirus. This demand for the development of the regent, which can be used for academic and therapeutic applications. The present data provide the biochemical characterization of synthetically developed monoclonal antibodies for the...
Autores principales: | Mishra, Nawneet, Teyra, Joan, Boytz, RuthMabel, Miersch, Shane, Merritt, Trudy N., Cardarelli, Lia, Gorelik, Maryna, Mihalic, Filip, Jemth, Per, Davey, Robert A., Sidhu, Sachdev S., Leung, Daisy W., Amarasinghe, Gaya K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232259/ https://www.ncbi.nlm.nih.gov/pubmed/35789908 http://dx.doi.org/10.1016/j.dib.2022.108415 |
Ejemplares similares
-
Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022) -
CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells
por: Mori, Hiroyuki, et al.
Publicado: (2022) -
Intracellular targeting with engineered proteins
por: Miersch, Shane, et al.
Publicado: (2016) -
Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants
por: Gorelik, Maryna, et al.
Publicado: (2016) -
Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation
por: Boytz, RuthMabel, et al.
Publicado: (2022)